Adagio Therapeutics, Inc. (ADGI) Balance Sheet Annual - Discounting Cash Flows
ADGI
Adagio Therapeutics, Inc.
ADGI (NASDAQ)
Period Ending: 2024
12-31
2021
12-31
Report Filing: 2025-03-20 2022-03-31
Total Current Assets 100.7 616.7
Cash and Short Term Investments 69.35 591.4
Cash & Equivalents 69.35 542.2
Short Term Investments 0 49.19
Receivables 10.91 0
Inventory 25.91 0
Other Current Assets -5.48 25.29
Total Assets 129.5 616.8
Total Non-Current Assets 28.83 0.083
Property, Plant and Equipment 2.89 0.083
Goodwill and Intangible Assets 0 0
Goodwill 0 0
Intangible Assets 0 0
Long Term Investments 0 0
Deferred Tax Assets 0 0
Other Long Term Assets 25.94 0
Total Current Liabilities 61.98 62.06
Accounts Payable 10.45 5.78
Notes Payable/Short Term Debt 1.3 0
Tax Payables 0 0
Deferred Revenue 0 0
Other Current Liabilities 50.22 56.28
Total Liabilities 61.98 62.07
Total Non-Current Liabilities 0 0.012
Total Long Term Debt 0 0
Deferred Tax Liabilities Non-Current 0 0
Deferred Revenue Non-Current 0 0
Capital Lease Obligations 0 0
Other Long Term Liabilities 0 0.012
Total Equity 0 558
Non-Controlling Interest 0 0
Total Stockholders' Equity 67.54 558
Retained Earnings -902 -292.1
Accumulated Other Earnings -0.005 -0.008
Common Stock 0.012 0.011
Preferred Stock 129.5 620.1
Additional Paid in Capital 969.5 230
Total Liabilities & Total Equity 129.5 620.1
Total Liabilities & Shareholders' Equity 129.5 616.8
Total Investments 0 49.19
Total Debt 1.3 0
Net Debt -68.05 -542.2
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program